Infographic: RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer
Infographic – Summary of the RaPiDS (GOG-3028): randomized Phase II study
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , |
---|---|
Format: | Bild |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | O’Malley, David M Randall, Leslie M Jackson, Camille Gunderson Coleman, Robert L Hays, John L. Moore, Kathleen N Naumann, R Wendel P. Rocconi, Rodney Slomovitz, Brian M Tewari, Krishnansu S Ancukiewicz, Marek Feliu, Waldo Ortuzar Monk, Bradley J |
description | Infographic – Summary
of the RaPiDS (GOG-3028): randomized Phase II study |
doi_str_mv | 10.25402/fon.15367260 |
format | Image |
fullrecord | <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_25402_fon_15367260</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_25402_fon_15367260</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_25402_fon_153672603</originalsourceid><addsrcrecordid>eNqVj7uOwjAURN1QIJaS_pZsEXASYFe0vDYViN3eunFsciXHRo4BQb__TXh9ANVMcWakw1gv5oNkPOLJUDs7iMfp5CuZ8Db7z6x2O4_7kuQUtrih-S_0V-tVlPLk-3MKHm3hKrqoAjYl1gqyDOpwKM7gNORo6kCGKswBjbMKnAeyIF2Vk8VAzsKJQgkXNKS9epA3QPkjSTQg0Tb9g7V0c6W6z-ywaLn4m_1EBQaUFJTY-2bqzyLm4q4hGg3x0kjf5a8ZiVVk</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>image</recordtype></control><display><type>image</type><title>Infographic: RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer</title><source>DataCite</source><creator>O’Malley, David M ; Randall, Leslie M ; Jackson, Camille Gunderson ; Coleman, Robert L ; Hays, John L. ; Moore, Kathleen N ; Naumann, R Wendel ; P. Rocconi, Rodney ; Slomovitz, Brian M ; Tewari, Krishnansu S ; Ancukiewicz, Marek ; Feliu, Waldo Ortuzar ; Monk, Bradley J</creator><creatorcontrib>O’Malley, David M ; Randall, Leslie M ; Jackson, Camille Gunderson ; Coleman, Robert L ; Hays, John L. ; Moore, Kathleen N ; Naumann, R Wendel ; P. Rocconi, Rodney ; Slomovitz, Brian M ; Tewari, Krishnansu S ; Ancukiewicz, Marek ; Feliu, Waldo Ortuzar ; Monk, Bradley J</creatorcontrib><description>Infographic – Summary
of the RaPiDS (GOG-3028): randomized Phase II study</description><identifier>DOI: 10.25402/fon.15367260</identifier><language>eng</language><publisher>Taylor & Francis</publisher><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,1894</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.25402/fon.15367260$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>O’Malley, David M</creatorcontrib><creatorcontrib>Randall, Leslie M</creatorcontrib><creatorcontrib>Jackson, Camille Gunderson</creatorcontrib><creatorcontrib>Coleman, Robert L</creatorcontrib><creatorcontrib>Hays, John L.</creatorcontrib><creatorcontrib>Moore, Kathleen N</creatorcontrib><creatorcontrib>Naumann, R Wendel</creatorcontrib><creatorcontrib>P. Rocconi, Rodney</creatorcontrib><creatorcontrib>Slomovitz, Brian M</creatorcontrib><creatorcontrib>Tewari, Krishnansu S</creatorcontrib><creatorcontrib>Ancukiewicz, Marek</creatorcontrib><creatorcontrib>Feliu, Waldo Ortuzar</creatorcontrib><creatorcontrib>Monk, Bradley J</creatorcontrib><title>Infographic: RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer</title><description>Infographic – Summary
of the RaPiDS (GOG-3028): randomized Phase II study</description><fulltext>true</fulltext><rsrctype>image</rsrctype><creationdate>2021</creationdate><recordtype>image</recordtype><sourceid>PQ8</sourceid><recordid>eNqVj7uOwjAURN1QIJaS_pZsEXASYFe0vDYViN3eunFsciXHRo4BQb__TXh9ANVMcWakw1gv5oNkPOLJUDs7iMfp5CuZ8Db7z6x2O4_7kuQUtrih-S_0V-tVlPLk-3MKHm3hKrqoAjYl1gqyDOpwKM7gNORo6kCGKswBjbMKnAeyIF2Vk8VAzsKJQgkXNKS9epA3QPkjSTQg0Tb9g7V0c6W6z-ywaLn4m_1EBQaUFJTY-2bqzyLm4q4hGg3x0kjf5a8ZiVVk</recordid><startdate>20210819</startdate><enddate>20210819</enddate><creator>O’Malley, David M</creator><creator>Randall, Leslie M</creator><creator>Jackson, Camille Gunderson</creator><creator>Coleman, Robert L</creator><creator>Hays, John L.</creator><creator>Moore, Kathleen N</creator><creator>Naumann, R Wendel</creator><creator>P. Rocconi, Rodney</creator><creator>Slomovitz, Brian M</creator><creator>Tewari, Krishnansu S</creator><creator>Ancukiewicz, Marek</creator><creator>Feliu, Waldo Ortuzar</creator><creator>Monk, Bradley J</creator><general>Taylor & Francis</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20210819</creationdate><title>Infographic: RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer</title><author>O’Malley, David M ; Randall, Leslie M ; Jackson, Camille Gunderson ; Coleman, Robert L ; Hays, John L. ; Moore, Kathleen N ; Naumann, R Wendel ; P. Rocconi, Rodney ; Slomovitz, Brian M ; Tewari, Krishnansu S ; Ancukiewicz, Marek ; Feliu, Waldo Ortuzar ; Monk, Bradley J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_25402_fon_153672603</frbrgroupid><rsrctype>images</rsrctype><prefilter>images</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>online_resources</toplevel><creatorcontrib>O’Malley, David M</creatorcontrib><creatorcontrib>Randall, Leslie M</creatorcontrib><creatorcontrib>Jackson, Camille Gunderson</creatorcontrib><creatorcontrib>Coleman, Robert L</creatorcontrib><creatorcontrib>Hays, John L.</creatorcontrib><creatorcontrib>Moore, Kathleen N</creatorcontrib><creatorcontrib>Naumann, R Wendel</creatorcontrib><creatorcontrib>P. Rocconi, Rodney</creatorcontrib><creatorcontrib>Slomovitz, Brian M</creatorcontrib><creatorcontrib>Tewari, Krishnansu S</creatorcontrib><creatorcontrib>Ancukiewicz, Marek</creatorcontrib><creatorcontrib>Feliu, Waldo Ortuzar</creatorcontrib><creatorcontrib>Monk, Bradley J</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>O’Malley, David M</au><au>Randall, Leslie M</au><au>Jackson, Camille Gunderson</au><au>Coleman, Robert L</au><au>Hays, John L.</au><au>Moore, Kathleen N</au><au>Naumann, R Wendel</au><au>P. Rocconi, Rodney</au><au>Slomovitz, Brian M</au><au>Tewari, Krishnansu S</au><au>Ancukiewicz, Marek</au><au>Feliu, Waldo Ortuzar</au><au>Monk, Bradley J</au><format>book</format><genre>unknown</genre><ristype>GEN</ristype><title>Infographic: RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer</title><date>2021-08-19</date><risdate>2021</risdate><abstract>Infographic – Summary
of the RaPiDS (GOG-3028): randomized Phase II study</abstract><pub>Taylor & Francis</pub><doi>10.25402/fon.15367260</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | DOI: 10.25402/fon.15367260 |
ispartof | |
issn | |
language | eng |
recordid | cdi_datacite_primary_10_25402_fon_15367260 |
source | DataCite |
title | Infographic: RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T23%3A40%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=O%E2%80%99Malley,%20David%20M&rft.date=2021-08-19&rft_id=info:doi/10.25402/fon.15367260&rft_dat=%3Cdatacite_PQ8%3E10_25402_fon_15367260%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |